$50,000 of CHARTER COMMUNICATIONS INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Communications and Technology Issues. Rural Broadband Issues. Broadband Adoption Issues. Infrastructure Issues. Spectrum Issues. Security Act CISA Reauthorization."
You can find more data on corporate lobbying on Quiver Quantitative.
CHTR Insider Trading Activity
CHTR insiders have traded $CHTR stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CHTR stock by insiders over the last 6 months:
- CHRISTOPHER L WINFREY (President and CEO) purchased 3,670 shares for an estimated $1,002,258
- DAVID C MERRITT sold 1,200 shares for an estimated $271,416
- BALAN NAIR purchased 360 shares for an estimated $98,715
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CHTR Hedge Fund Activity
We have seen 329 institutional investors add shares of CHTR stock to their portfolio, and 503 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TAM CAPITAL MANAGEMENT INC. added 3,103,456 shares (+inf%) to their portfolio in Q3 2025, for an estimated $853,776,262
- PZENA INVESTMENT MANAGEMENT LLC removed 2,244,951 shares (-84.7%) from their portfolio in Q3 2025, for an estimated $617,597,244
- STATE STREET CORP added 1,475,383 shares (+22.7%) to their portfolio in Q3 2025, for an estimated $405,885,240
- CAPITAL RESEARCH GLOBAL INVESTORS added 1,189,287 shares (+inf%) to their portfolio in Q3 2025, for an estimated $327,178,800
- VANGUARD GROUP INC added 1,130,648 shares (+13.7%) to their portfolio in Q3 2025, for an estimated $311,046,918
- AQR CAPITAL MANAGEMENT LLC added 1,109,703 shares (+826.1%) to their portfolio in Q3 2025, for an estimated $305,284,843
- PRICE T ROWE ASSOCIATES INC /MD/ removed 971,122 shares (-65.6%) from their portfolio in Q3 2025, for an estimated $267,160,517
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CHTR Analyst Ratings
Wall Street analysts have issued reports on $CHTR in the last several months. We have seen 3 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Benchmark issued a "Buy" rating on 11/03/2025
- Citigroup issued a "Buy" rating on 11/03/2025
- B of A Securities issued a "Buy" rating on 09/24/2025
- Goldman Sachs issued a "Sell" rating on 09/02/2025
- Barclays issued a "Underweight" rating on 07/28/2025
To track analyst ratings and price targets for CHTR, check out Quiver Quantitative's $CHTR forecast page.
CHTR Price Targets
Multiple analysts have issued price targets for $CHTR recently. We have seen 10 analysts offer price targets for $CHTR in the last 6 months, with a median target of $272.5.
Here are some recent targets:
- John Hodulik from UBS set a target price of $233.0 on 12/22/2025
- Steven Cahall from Wells Fargo set a target price of $240.0 on 11/03/2025
- Matthew Harrigan from Benchmark set a target price of $425.0 on 11/03/2025
- Laurent Yoon from Bernstein set a target price of $280.0 on 11/03/2025
- Jonathan Atkin from RBC Capital set a target price of $265.0 on 11/03/2025
- Kannan Venkateshwar from Barclays set a target price of $200.0 on 11/03/2025
- Michael Rollins from Citigroup set a target price of $310.0 on 11/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
